LON:OKYO

OKYO Pharma (OKYO) Share Forecast, Price & News

GBX 2.76

-0.09 (-3.16%)

(As of 05/27/2022 02:36 PM ET)

Add

Compare

Today's Range: 2.76
▼
2.98
50-Day Range: 2.85
▼
7.15
52-Week Range: 2.75
▼
9

Volume: 175,255 shs
Average Volume: 278,663 shs
Market Capitalization: £37.93 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive OKYO News and Ratings via Email

Sign-up to receive the latest news and ratings for OKYO Pharma and its competitors with MarketBeat's FREE daily newsletter.

About OKYO Pharma

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. It is developing OK-101 for the treatment of dry eye disease; and OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. The company is also developing chemerin and chemerin analogues to treat the cytokine release syndrome associated with COVID-19 infections and other conditions, such as acute respiratory distress syndrome. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

May 20, 2022 | proactiveinvestors.com

Okyo Pharma successfully closes US$2.5mln US fundraiser

May 20, 2022 | americanbankingnews.com

Insider Buying: OKYO Pharma Limited (LON:OKYO) Insider Buys 5,800,000 Shares of Stock

May 19, 2022 | finanznachrichten.de

OKYO Pharma LTD: OKYO Pharma Limited Announces Closing of Public Offering and Nasdaq Listing

May 19, 2022 | finance.yahoo.com

OKYO Pharma Limited Announces Closing of Public Offering and Nasdaq Listing

May 18, 2022 | finanznachrichten.de

OKYO Pharma LTD: OKYO Pharma Limited Announces Pricing of Public Offering and Nasdaq Listing

May 18, 2022 | finanznachrichten.de

OKYO Pharma LTD: OKYO Pharma Limited - PDMR Dealing

May 18, 2022 | in.investing.com

OKYO Pharma IPO Opens 13% Higher

May 18, 2022 | seekingalpha.com

OKYO Pharma stock climbs 10% following downsized $2.5M US IPO

May 18, 2022 | seekingalpha.com

OKYO Pharma stock slides 16% in wake of downsized US IPO

May 18, 2022 | finance.yahoo.com

OKYO Pharma ("OKYO" or the "Company") - Announces Two Presentations at the 2022 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

May 18, 2022 | finance.yahoo.com

OKYO Pharma Limited Announces Pricing of Public Offering and Nasdaq Listing

May 18, 2022 | finance.yahoo.com

OKYO Pharma Limited Announces Pricing of Initial Public Offering of ADSs in the U.S. with director participation

May 18, 2022 | finance.yahoo.com

Here's Why We're Watching OKYO Pharma's (LON:OKYO) Cash Burn Situation

See More Headlines

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Biotechnology
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:OKYO
Previous Symbol
CUSIP: N/A
CIK: N/A
Web: www.okyopharma.com
Phone: 44 20 7495 2379
Fax: N/A
Employees: 6
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: GBX 0.36 per share
Price / Cash Flow: 7.75
Book Value: GBX 0.40 per share
Price / Book: 6.90

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: 1.65
Current Ratio: 8.95
Quick Ratio: 8.89

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: 1,374,405,000
Free Float: N/A
Market Cap: £37.93 million
Optionable: Not Optionable

Company Calendar

Today: 5/27/2022
Next Earnings (Estimated): 8/01/2022

MarketRank^™

Overall MarketRank^™

1.19 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for OKYO Pharma.

4.3 Community Rank

Outperform Votes
OKYO Pharma has received 7 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
OKYO Pharma has received 4 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
OKYO Pharma has received 63.64% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about OKYO Pharma and other stocks. Vote “Outperform” if you believe OKYO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe OKYO will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
OKYO Pharma does not currently pay a dividend.
Dividend Growth
OKYO Pharma does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, OKYO Pharma insiders have bought more of their company's stock than they have sold. Specifically, they have bought £348,000 in company stock and sold GBX 0 in company stock.

0.0 Earnings and Valuation

Price to Earnings Ratio vs. the Market
The P/E ratio of OKYO Pharma is -5.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of OKYO Pharma is -5.52, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
OKYO Pharma has a P/B Ratio of 6.90. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

OKYO Pharma (LON:OKYO) Frequently Asked Questions

When is OKYO Pharma's next earnings date?: OKYO Pharma is scheduled to release its next quarterly earnings announcement on Monday, August 1st 2022.
View our earnings forecast for OKYO Pharma.
Who are OKYO Pharma's key executives?: OKYO Pharma's management team includes the following people:
Dr. Gary S. Jacob Ph.D., CEO & Exec. Director (Age 75, Pay $290.84k)
Mr. Michael Paul Beck, Founder (Age 65)
Ms. Keeren Shah, Chief Financial Officer (Age 45)
Dr. Rajkumar Patil Ph.D., Chief Scientific Officer (Age 64)
Who are some of OKYO Pharma's key competitors?: Some companies that are related to OKYO Pharma include Ampliphi Biosciences (APHB), Circassia Group (CIR), Arix Bioscience (ARIX), Faron Pharmaceuticals Oy (FARN), Tiziana Life Sciences (TILS), Verseon (VSN), Aptose Biosciences (APS), Arecor Therapeutics (AREC), e-therapeutics (ETX), Novacyt (NCYT), Scythian Biosciences (SCYB), 138267 (COM.TO) (COM), Novoheart (NVH), Scancell (SCLP) and Open Orphan (ORPH).
View all of OKYO's competitors.
What is OKYO Pharma's stock symbol?: OKYO Pharma trades on the London Stock Exchange (LON) under the ticker symbol "OKYO."
How do I buy shares of OKYO Pharma?: Shares of OKYO and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
What is OKYO Pharma's stock price today?: One share of OKYO stock can currently be purchased for approximately GBX 2.76.
How much money does OKYO Pharma make?: OKYO Pharma has a market capitalization of £37.93 million.
How many employees does OKYO Pharma have?: OKYO Pharma employs 6 workers across the globe.
What is OKYO Pharma's official website?: The official website for OKYO Pharma is www.okyopharma.com.
How can I contact OKYO Pharma?: The company can be reached via phone at 44 20 7495 2379.

This page was last updated on 5/27/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

OKYO Pharma (OKYO) Share Forecast, Price & News

About OKYO Pharma

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Company Calendar